Literature DB >> 2390668

Modification of the ischaemic-induced contraction in the sheep circumflex coronary artery by various pharmacological antagonists.

Y W Kwan1, R M Wadsworth, K A Kane.   

Abstract

1. Sheep isolated circumflex coronary artery rings were exposed to simulated ischaemia (increased K+ reduced pH, hypoxia, reduced glucose and addition of lactate). Simulated ischaemia caused a transient relaxation lasting approximately 5 min followed by a sustained contraction that was reversible on washing with oxygenated Krebs solution. 2. Haemolysate caused a rise in baseline tension and augmented the ischaemic contraction. 3. The ischaemic contraction was abolished by BW 755C 5 microM and reduced by indomethacin 1 microM, quinacrine 50 microM or the thromboxane A2 antagonist BM 13177 10 microM. The leukotriene D4 antagonist, ICI 198615, had no effect. 4. The ischaemic-induced contraction was enhanced by propranolol 1 microM, methiothepin 1 microM and reduced by ketanserin 1 microM. 5. The ischaemic contraction was markedly inhibited by trypsin (1 mu ml-1) and by verapamil, cromakalim or sodium nitroprusside. 6. The following had no or little effect on the ischaemic contraction: Sar1-Thr8-angiotensin II, mepyramine, atropine, the spin trapping agent PBN or the free radical scavenger dimethylsulphoxide. Superoxide dismutase caused a slight enhancement. 7. The ischaemic-induced contraction was abolished by the simultaneous administration, at subthreshold concentrations, either of two vasodilators (iloprost and adenosine) or of a vasodilator and a vasoconstrictor (iloprost and U46619). 8. The ischaemic relaxation phase was reduced by propranolol and indomethacin, abolished by haemolysate and enhanced by quinacrine or cromakalim. 9. It is concluded that the ischaemic-induced contraction is caused by mediators released from the endothelium including a product of the lipoxygenase pathway. There is also evidence that simulated ischaemia causes the release of noradrenaline and 5-hydroxytryptamine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390668      PMCID: PMC1917768          DOI: 10.1111/j.1476-5381.1990.tb15819.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

Authors:  J D Folts; E B Crowell; G G Rowe
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

2.  Responsiveness of sheep isolated coronary artery rings under simulated myocardial ischaemia.

Authors:  Y W Kwan; R M Wadsworth; K A Kane
Journal:  Eur J Pharmacol       Date:  1989-09-01       Impact factor: 4.432

3.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

4.  The importance of phospholipase-A2 in prostaglandin biosynthesis.

Authors:  R J Flower; G J Blackwell
Journal:  Biochem Pharmacol       Date:  1976-02-01       Impact factor: 5.858

Review 5.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

6.  The time of onset and severity of acidosis in myocardial ischaemia.

Authors:  S M Cobbe; P A Poole-Wilson
Journal:  J Mol Cell Cardiol       Date:  1980-08       Impact factor: 5.000

7.  1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets.

Authors:  G J Blackwell; R J Flower
Journal:  Prostaglandins       Date:  1978-09

8.  Hypoxic contraction of isolated canine coronary artery. Mediation by potassium-dependent exocytosis of norepinephrine.

Authors:  L J Borda; R Shuchleib; P D Henry
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

9.  Effects of uptake inhibitors on responses of sheep coronary arteries to catecholamines and sympathetic nerve stimulation.

Authors:  F Brine; E J Cornish; R C Miller
Journal:  Br J Pharmacol       Date:  1979-12       Impact factor: 8.739

10.  Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.

Authors:  P D Hirsh; L D Hillis; W B Campbell; B G Firth; J T Willerson
Journal:  N Engl J Med       Date:  1981-03-19       Impact factor: 91.245

View more
  1 in total

1.  Non-endothelial endothelin counteracts hypoxic vasodilation in porcine large coronary arteries.

Authors:  Elise R Hedegaard; Edgaras Stankevicius; Ulf Simonsen; Ole Fröbert
Journal:  BMC Physiol       Date:  2011-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.